Adverse effects of dupilumab in a child with atopic dermatitis: A case report of anaphylaxis and literature review
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. It usually develops in childhood and may persist into adulthood. Dupilumab is a fully human monoclonal antibody directed against interleukin-4R-alpha, the common chain of interleukin-4 and interleukin-13 receptors....
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-03-01
|
| Serie: | Allergy Medicine |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2949913525000072 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|